Mercado de Heparina: Tendencias Globales de la Industria, Participación, Tamaño, Crecimiento, Oportunidad y Pronóstico 2024-2032

Mercado de Heparina: Tendencias Globales de la Industria, Participación, Tamaño, Crecimiento, Oportunidad y Pronóstico 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A16823

Language of the Report – English

Sin embargo, el informe puede estar disponible en español por un costo adicional.

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Heparin Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Breakup by Product
    5.5    Market Breakup by Source
    5.6    Market Breakup by Mode of Administration
    5.7    Market Breakup by Application
    5.8    Market Breakup by End-User
    5.9    Market Breakup by Distribution Channel
    5.10    Market Breakup by Region
    5.11    Market Forecast
6   Market Breakup by Product
    6.1    Unfractionated Heparin
        6.1.1    Market Trends
        6.1.2    Market Forecast
    6.2    Low Molecular Weight Heparin (LMWH)
        6.2.1    Market Trends
        6.2.2    Market Forecast
    6.3    Ultra-Low Molecular Weight Heparin (ULMWH)
        6.3.1    Market Trends
        6.3.2    Market Forecast
7   Market Breakup by Source
    7.1    Bovine
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Porcine
        7.2.1    Market Trends
        7.2.2    Market Forecast
8   Market Breakup by Mode of Administration
    8.1    Oral
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Parenteral
        8.2.1    Market Trends
        8.2.2    Market Forecast
9   Market Breakup by Application
    9.1    Atrial Fibrillation & Heart Attack
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    Stroke
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    Deep Vein Thrombosis (DVT)
        9.3.1    Market Trends
        9.3.2    Market Forecast
    9.4    Pulmonary Embolism (PE)
        9.4.1    Market Trends
        9.4.2    Market Forecast
    9.5    Others 
        9.5.1    Market Trends
        9.5.2    Market Forecast
10  Market Breakup by End-User
    10.1    Hospitals
        10.1.1    Market Trends
        10.1.2    Market Forecast
    10.2    Clinics
        10.2.1    Market Trends
        10.2.2    Market Forecast
    10.3    Homecare Settings
        10.3.1    Market Trends
        10.3.2    Market Forecast
    10.4    Ambulatory Surgical Centers
        10.4.1    Market Trends
        10.4.2    Market Forecast
    10.5    Others 
        10.5.1    Market Trends
        10.5.2    Market Forecast
11  Market Breakup by Distribution Channel
    11.1    Hospital Pharmacies
        11.1.1    Market Trends
        11.1.2    Market Forecast
    11.2    Retail Pharmacies
        11.2.1    Market Trends
        11.2.2    Market Forecast
    11.3    Drug Stores
        11.3.1    Market Trends
        11.3.2    Market Forecast
    11.4    Online Stores
        11.4.1    Market Trends
        11.4.2    Market Forecast
    11.5    Others
        11.5.1    Market Trends
        11.5.2    Market Forecast
12  Market Breakup by Region
    12.1    Europe
        12.1.1    Market Trends
        12.1.2    Market Forecast
    12.2    North America
        12.2.1    Market Trends
        12.2.2    Market Forecast
    12.3    Asia Pacific
        12.3.1    Market Trends
        12.3.2    Market Forecast
    12.4    Middle East and Africa
        12.4.1    Market Trends
        12.4.2    Market Forecast
    12.5    Latin America
        12.5.1    Market Trends
        12.5.2    Market Forecast
13  SWOT Analysis
    13.1    Overview
    13.2    Strengths
    13.3    Weaknesses
    13.4    Opportunities
    13.5    Threats
14  Value Chain Analysis
15  Porter’s Five Forces Analysis

    15.1    Overview
    15.2    Bargaining Power of Buyers
    15.3    Bargaining Power of Suppliers
    15.4    Degree of Competition
    15.5    Threat of New Entrants
    15.6    Threat of Substitutes
16  Price Analysis
17  Competitive Landscape

    17.1    Market Structure
    17.2    Key Players
    17.3    Profiles of Key Players
        17.3.1    GlaxoSmithKline Plc
        17.3.2    Shenzhen Hepalink Pharmaceutical Co., Ltd
        17.3.3    Pfizer Inc.
        17.3.4    LEO Pharma A/S
        17.3.5    Sanofi S.A.
        17.3.6    Dr. Reddy’s Laboratories Ltd.
        17.3.7    Teva Pharmaceutical Industries Ltd.
        17.3.8     Aspen Holdings
        17.3.9     Baxter International Inc.
        17.3.10     Hebei Changshan Biochemical Pharmaceutical Co. Ltd.
        17.3.11     Sandoz International GmbH
        17.3.12     Opocrin S.p.A.
        17.3.13     Sichuan Deebio Pharmaceutical Co., Ltd.
        17.3.14     Dongying Tiandong Pharmaceutical Co., Ltd.

Mercado de Heparina: Tendencias Globales de la Industria, Participación, Tamaño, Crecimiento, Oportunidad y Pronóstico 2024-2032
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials